NCT01321099

Brief Summary

Iron deficiency (ID) is still a main public health problem in sub-Saharan Africa. Iron deficient children have an increased risk for anemia which is associated with adverse infant development that might be partly irreversible. In sub-Saharan Africa, the etiology of ID in children is multifactoral; but the major causes are low iron dietary bioavailability and intake from monotonous cereal-based complementary foods. Children \< 5 years old can benefit from iron-fortified complementary foods; however, these fortified complementary foods are often not adapted to the requirements of children in specific setting. The investigators developed a complementary food fortificant (CFF) which is added to local porridge and is deemed to meet the nutrient intake requirement for iron in children 1-3 years of age. The CFF is lipid-based and can therefore, if regularly used, increase the daily energy intake of children which is often too low in developing countries with cereal-based diets. The iron absorption from the mixture of CFF and porridge has to be optimized because it contains quite a high amount of phytate, a well-known inhibitor of iron absorption. To optimize iron absorption the investigators are planning three iron absorption studies using different compounds of iron (FeSO4 + NaFeEDTA), additional vitamin C and phytase, which is able to degrade phytate. In the first study, iron absorption will be determined from a mixture of CFF and porridge fortified with 1) 6 mg FeSO4 and 2) 6 mg FeSO4 plus additional vitamin C. In the second study, the test meals will be fortified with 1) 6 mg FeSO4 and 2) a mixture of 3 mg FeSO4 + 3 mg NaFeEDTA. In the third study, test meals will be fortified with 1) 6 mg FeSO4, 2) 6 mg FeSO4 plus phytase, and 3) 6 mg FeSO4 plus additional vitamin C and phytase. Iron absorption will be determined by incorporation of labeled iron into erythrocytes, 14 days after the administration of a test meal containing labeled iron (stable isotope technique). Sixty apparently healthy Beninese children 12-36 months of age with a body weight \> 8.3 kg will be included in the study. Additionally, the investigators will test acceptability of CFFs based on different composition formulas by interviewing the parents/legal guardians of the children after feeding the CFF for a defined period. The results of these studies will provide important insights to optimize the iron absorption of young children from a CFF mixed with local traditional porridge in developing countries. Furthermore the studies will provide information on the acceptability of CFFs in such a setting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 22, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 23, 2011

Completed
1 month until next milestone

Study Start

First participant enrolled

May 1, 2011

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2012

Completed
Last Updated

November 8, 2012

Status Verified

November 1, 2012

Enrollment Period

1.1 years

First QC Date

March 22, 2011

Last Update Submit

November 7, 2012

Conditions

Keywords

Iron absorptionComplementary food fortificantYoung children

Outcome Measures

Primary Outcomes (1)

  • Iron isotope ratio in blood samples

    Whole blood samples will be collected to measure the shift in iron isotope ratios 16 days after administration of isotopic label in the first test meal. First test meal on study day 1, Second test meal on study day 2, Third (last) test meal on study day 3, Measurement of iron isotopic shift in blood samples collected on study day 17

    Study day 17 (16 days after administration of isotopic label in the first test meal/End of the study)

Study Arms (3)

NaFeEDTA

EXPERIMENTAL
Other: NaFeEDTA

Phatase

EXPERIMENTAL
Other: Phytase

Vitamin C

EXPERIMENTAL
Other: Vitamin C

Interventions

Labeled iron as FeSO4 or NaFeEDTA added to a test meal

NaFeEDTA
PhytaseOTHER

Labeled iron as FeSO4 added to a test meal with or without phytase and with or without vitamin C

Phatase

Labeled iron as FeSO4 added to a test meal with or without vitamin C

Vitamin C

Eligibility Criteria

Age12 Months - 36 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Female or male children, 12 - 36 months of age
  • A body weight of at least 8.3 kg; weight for age ≥ -3 Z-score
  • No malaria parasites in the blood smear + negative malaria rapid test
  • No hematuria
  • No intake of mineral/vitamin supplements 2 weeks before and during the study
  • No metabolic or gastrointestinal disorders

You may not qualify if:

  • Fever (body temperature \> 37.5 °C)
  • Severe anemia (hemoglobin \< 8.0 g/dl)
  • Regular intake of medication
  • Blood transfusion or significant blood loss (accident, surgery) over the past 4 months
  • Currently participating in another clinical trial or having participated in another clinical trial during the last 3 months prior to the beginning of this study
  • Former participation in a study involving administration of iron stable isotopes
  • Subject who cannot be expected to comply with study protocol
  • Eating disorders or food allergy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Abomey-Calavi

Cotonou, Cotonou, 562, Benin

Location

MeSH Terms

Conditions

Iron DeficienciesAnemia

Interventions

Fe(III)-EDTA6-PhytaseAscorbic Acid

Condition Hierarchy (Ancestors)

Iron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesHematologic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Phosphoric Monoester HydrolasesEsterasesHydrolasesEnzymesEnzymes and CoenzymesSugar AcidsAcids, AcyclicCarboxylic AcidsOrganic ChemicalsHydroxy AcidsCarbohydrates

Study Officials

  • Richard Hurrell, Prof

    Swiss Federal Institute of Technology (ETH Zürich)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof

Study Record Dates

First Submitted

March 22, 2011

First Posted

March 23, 2011

Study Start

May 1, 2011

Primary Completion

June 1, 2012

Study Completion

September 1, 2012

Last Updated

November 8, 2012

Record last verified: 2012-11

Locations